Mission
Co-D Therapeutics’ mission is to aggressively develop its lead product Triolimus to treat multiple types of cancer. We seek to position Co-D as a leader in the evolving field of nano-medicine drug combinations for cancer treatment.

Vision
Co-D Therapeutic is dedicated to bringing to market first-in-class, innovative combination nano-medicines with high safety profiles to treat cancer and improve patients’ lives